• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD MAX¿ GBS; SEE H.10

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD MAX¿ GBS; SEE H.10 Back to Search Results
Model Number 441772
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/25/2023
Event Type  malfunction  
Manufacturer Narrative
Common device name:nucleic acid amplification assay system, group b streptococcus, direct specimen test medical device type or (procode) : njr, ooi.Initial reporter addr 1: (b)(6).A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that bd max¿ gbs discrepancy with the results occurred after rerun there was one negative result instead of a positive.The following information was provided by the initial reporter: gbs run 1909 - 7 samples - 2 pos; gbs run 1910 - 4 samples, including the 2 pos from run 1909: 1 of the repeats confirmed pos, and the other one is neg.
 
Event Description
It was reported that bd max¿ gbs discrepancy with the results occurred after rerun there was one negative result instead of a positive.The following information was provided by the initial reporter: gbs run 1909 - 7 samples - 2 pos; gbs run 1910 - 4 samples, including the 2 pos from run 1909: 1 of the repeats confirmed pos, and the other one is neg.
 
Manufacturer Narrative
H.6 investigation summary: the complaint investigation for discrepant results when using the bd max gbs (ref.(b)(4)) lot 2203774 was performed by the review of the manufacturing records, analysis of the customer¿s data and verification of the complaints history.Review of the manufacturing records of the bd max gbs lot 2203774 indicated that the lot was manufactured according to specifications and met performance requirements.Customer complained about discrepant results when using the bd max¿ gbs assay.Two samples gave a gbs positive result in the initial run but one of them was negative upon repeat testing.Customer provided two run files #1909 and 1910 from instrument (b)(6) for investigation.Analysis of the run files revealed that in run 1909, 7 samples were tested with the bd max¿ gbs assay and two of them gave a positive gbs result.When retested in run 1910, one of them gave a negative result.Manual pcr curve adjudication of discrepant samples was performed.Pcr curves analysis revealed that in run 1909, both samples obtained late amplification of the gbs target (ct >29), which is unexpected with the gbs assay.Such late ct values are unexpected with the gbs assay, since samples are tested following an enrichment step.Based on the investigation, the most probable cause for the customer¿s discrepant results is suspected of being cross contamination introduced during the sample preparation at the customer¿s site or environmental contamination.Nevertheless, manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.Nonetheless, no reagents issue is suspected.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max gbs lot 2203774.The root cause was not identified.However, a cross contamination introduced during the sample preparation at the customer¿s site can explain the customer¿s discrepant results.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and a preventive action plan since no new hazard was identified.Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ GBS
Type of Device
SEE H.10
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16380502
MDR Text Key309595562
Report Number1119779-2023-00119
Device Sequence Number1
Product Code NJR
UDI-Device Identifier00382904417727
UDI-Public00382904417727
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K111860
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number441772
Device Catalogue Number441772
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2023
Initial Date FDA Received02/15/2023
Supplement Dates Manufacturer Received03/07/2023
Supplement Dates FDA Received03/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-